This website is intended for healthcare professionals who are currently residing and practising in the United Kingdom and Ireland.
This is a promotional website designed, built and funded by Gilead Sciences Ltd.
UK-AMB-1047 | January 2024 © 2024 Gilead Sciences, Inc. All rights reserved
Intensive Care Society State of the Art meeting 2022: Diagnosis of IFIs in the ICU
Intensive Care Society State of the Art meeting 2022: The hidden threat of IFIs in the ICU
AmBisome® (liposomal amphotericin B): a successful example of nanotechnology applied to pharma
Intensive Care Society State of the Art meeting 2022: Diagnosis of IFIs in the ICU
Prescribing information can be found at the top or bottom of this webpage
UK-AMB-0213
Date of preparation: August 2021.
Intensive Care Society State of the Art meeting 2022: Diagnosis of IFIs in the ICU
ViewIntensive Care Society State of the Art meeting 2022: The hidden threat of IFIs in the ICU
ViewAmBisome® (liposomal amphotericin B): a successful example of nanotechnology applied to pharma
ViewIntensive Care Society State of the Art meeting 2022: Diagnosis of IFIs in the ICU
ViewThis link will take you to a non-Gilead website. Gilead does not recommend, endorse or accept liability for sites controlled by third parties.